Investigational drug restores calcium levels in rare genetic disorder

An investigational drug, encaleret, restored calcium levels in people with autosomal dominant hypocalcemia type 1 (ADH1), a rare genetic disorder marked by an imbalance of calcium in the blood and urine, as well as abnormally low levels of parathyroid hormone, which regulates blood calcium levels.

Advamed CEO congratulates Trump, stresses need for public policy support

Advamed CEO Scott Whitaker congratulated President-elect Donald Trump on Friday for winning a second term and stressed the need for public policy to support innovation

November 11, 2024

Tryp Therapeutics and Exopharm Limited Sign Definitive Agreement

Tryp Therapeutics Inc. (CSE:TRYP), a clinical-stage biotechnology company specializing in the development of intravenous-infused psilocin for diseases with high unmet medical needs, has been acquired.

December 12, 2023

Spear Bio secures $45 million in oversubscribed Series A financing to accelerate product launch for protein research and disease diagnostics

WOBURN, Mass.–(BUSINESS WIRE)–Spear Bio Inc., a biotechnology company enabling the measurement of protein molecules down to dozens of copies with ubiquitous qPCR equipment, announced the

July 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.